These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 21501398)

  • 1. Imaging characteristics following 90yttrium microsphere treatment for unresectable liver cancer.
    Bester L; Hobbins PG; Wang SC; Salem R
    J Med Imaging Radiat Oncol; 2011 Apr; 55(2):111-8. PubMed ID: 21501398
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical care and technical recommendations for 90yttrium microsphere treatment of liver cancer.
    Wang SC; Bester L; Burnes JP; Clouston JE; Hugh TJ; Little AF; Padbury RT; Price D
    J Med Imaging Radiat Oncol; 2010 Jun; 54(3):178-87. PubMed ID: 20598004
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Patient selection and activity planning guide for selective internal radiotherapy with yttrium-90 resin microspheres.
    Lau WY; Kennedy AS; Kim YH; Lai HK; Lee RC; Leung TW; Liu CS; Salem R; Sangro B; Shuter B; Wang SC
    Int J Radiat Oncol Biol Phys; 2012 Jan; 82(1):401-7. PubMed ID: 20950954
    [TBL] [Abstract][Full Text] [Related]  

  • 4. FDG-PET-CT and whole-body MRI for triage in patients planned for radioembolisation therapy.
    Schmidt GP; Paprottka P; Jakobs TF; Hoffmann RT; Baur-Melnyk A; Haug A; Notohamiprodjo M; Baur-Melnyk A; Nikolaou K; Reiser MF; Rist C
    Eur J Radiol; 2012 Mar; 81(3):e269-76. PubMed ID: 21398060
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Yttrium-90 microsphere-selective internal radiation therapy with chemotherapy (chemo-SIRT) for colorectal cancer liver metastases: an in vivo double-arm-controlled phase II trial.
    Gulec SA; Pennington K; Wheeler J; Barot TC; Suthar RR; Hall M; Schwartzentruber D
    Am J Clin Oncol; 2013 Oct; 36(5):455-60. PubMed ID: 22643569
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mid-term results in otherwise treatment refractory primary or secondary liver confined tumours treated with selective internal radiation therapy (SIRT) using (90)Yttrium resin-microspheres.
    Jakobs TF; Hoffmann RT; Poepperl G; Schmitz A; Lutz J; Koch W; Tatsch K; Lubiensky A; Reiser MF; Helmberger T
    Eur Radiol; 2007 May; 17(5):1320-30. PubMed ID: 17149621
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Response of liver metastases after treatment with yttrium-90 microspheres: role of size, necrosis, and PET.
    Miller FH; Keppke AL; Reddy D; Huang J; Jin J; Mulcahy MF; Salem R
    AJR Am J Roentgenol; 2007 Mar; 188(3):776-83. PubMed ID: 17312068
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 90Y microsphere (TheraSphere) treatment for unresectable colorectal cancer metastases of the liver: response to treatment at targeted doses of 135-150 Gy as measured by [18F]fluorodeoxyglucose positron emission tomography and computed tomographic imaging.
    Lewandowski RJ; Thurston KG; Goin JE; Wong CY; Gates VL; Van Buskirk M; Geschwind JF; Salem R
    J Vasc Interv Radiol; 2005 Dec; 16(12):1641-51. PubMed ID: 16371530
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A retrospective analysis of selective internal radiation therapy (SIRT) with yttrium-90 microspheres in patients with unresectable hepatic malignancies.
    Omed A; Lawrance JA; Murphy G; Laasch HU; Wilson G; Illidge T; Tipping J; Zivanovic M; Jeans S
    Clin Radiol; 2010 Sep; 65(9):720-8. PubMed ID: 20696299
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Profound transient thrombocytopenia associated with 90Yttrium microsphere therapy for inoperable hepatoma.
    Yang CW; Yen HH; Su WW; Chen YY; Soon MS
    South Med J; 2010 Dec; 103(12):1264-8. PubMed ID: 21037524
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Selective internal radiotherapy (radioembolization) and radiation therapy for HCC--current status and perspectives].
    Hilgard P; Müller S; Hamami M; Sauerwein WS; Haberkorn U; Gerken G; Antoch G
    Z Gastroenterol; 2009 Jan; 47(1):37-54. PubMed ID: 19156591
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Imaging of hepatocellular carcinoma after treatment with yttrium-90 microspheres.
    Keppke AL; Salem R; Reddy D; Huang J; Jin J; Larson AC; Miller FH
    AJR Am J Roentgenol; 2007 Mar; 188(3):768-75. PubMed ID: 17312067
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Radioembolisation with Yttrium-90 microspheres: an effective treatment modality for unresectable liver metastases.
    Bester L; Meteling B; Pocock N; Saxena A; Chua TC; Morris DL
    J Med Imaging Radiat Oncol; 2013 Feb; 57(1):72-80. PubMed ID: 23374558
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recommendations of the American Association of Physicists in Medicine on dosimetry, imaging, and quality assurance procedures for 90Y microsphere brachytherapy in the treatment of hepatic malignancies.
    Dezarn WA; Cessna JT; DeWerd LA; Feng W; Gates VL; Halama J; Kennedy AS; Nag S; Sarfaraz M; Sehgal V; Selwyn R; Stabin MG; Thomadsen BR; Williams LE; Salem R;
    Med Phys; 2011 Aug; 38(8):4824-45. PubMed ID: 21928655
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Selective Internal Radiation Therapy (SIRT) for liver metastases secondary to colorectal adenocarcinoma.
    Welsh JS; Kennedy AS; Thomadsen B
    Int J Radiat Oncol Biol Phys; 2006; 66(2 Suppl):S62-73. PubMed ID: 16979443
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recommendations for radioembolization of hepatic malignancies using yttrium-90 microsphere brachytherapy: a consensus panel report from the radioembolization brachytherapy oncology consortium.
    Kennedy A; Nag S; Salem R; Murthy R; McEwan AJ; Nutting C; Benson A; Espat J; Bilbao JI; Sharma RA; Thomas JP; Coldwell D
    Int J Radiat Oncol Biol Phys; 2007 May; 68(1):13-23. PubMed ID: 17448867
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 18F-FDG PET/CT predicts survival after radioembolization of hepatic metastases from breast cancer.
    Haug AR; Tiega Donfack BP; Trumm C; Zech CJ; Michl M; Laubender RP; Uebleis C; Bartenstein P; Heinemann V; Hacker M
    J Nucl Med; 2012 Mar; 53(3):371-7. PubMed ID: 22331219
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Initial outcome after selective intraarterial radionuclide therapy with yttrium-90 microspheres as salvage therapy for unresectable metastatic liver disease.
    Turkmen C; Ucar A; Poyanli A; Vatankulu B; Ozkan G; Basaran M; Serin K; Sanli Y; Adalet I
    Cancer Biother Radiopharm; 2013 Sep; 28(7):534-40. PubMed ID: 23647219
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluating 90Y-glass microsphere treatment response of unresectable colorectal liver metastases by [18F]FDG PET: a comparison with CT or MRI.
    Wong CY; Salem R; Raman S; Gates VL; Dworkin HJ
    Eur J Nucl Med Mol Imaging; 2002 Jun; 29(6):815-20. PubMed ID: 12029557
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Early dose response to yttrium-90 microsphere treatment of metastatic liver cancer by a patient-specific method using single photon emission computed tomography and positron emission tomography.
    Campbell JM; Wong CO; Muzik O; Marples B; Joiner M; Burmeister J
    Int J Radiat Oncol Biol Phys; 2009 May; 74(1):313-20. PubMed ID: 19362251
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.